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The HIV-1 accessory gene product Vpr can inhibit cell proliferation via cell cycle arrest at the G2 phase, and it can induce
apoptosis after G2 arrest. We found recently that C81, a carboxy-terminally truncated form of Vpr, induced apoptosis via G1
arrest but did not induce G2 arrest of the cell cycle. Thus, it seemed possible that expression of Vpr in cells might cause
apoptosis independently of the ability of Vpr to induce G2 arrest. We demonstrate here that Vpr-induced apoptosis occurs by
a mechanism that does not necessarily require induction of G2 arrest. First, it was found that the extent of apoptosis reached
a maximum even when few cells were arrested at the G2 phase of the cell cycle and was reduced in inverse proportion to
the increased induction of G2 arrest. Thus, the extent of induction of G2 arrest was not correlated with the extent of
Vpr-induced apoptosis. Furthermore, we replaced the Ile/Leu residues in the leucine zipper-like domain of Vpr with Ala or Pro
and used cells that expressed the mutant protein to demonstrate that Vpr caused apoptosis in a manner that was
independent of G2 arrest. Finally, replacement of Ile/Leu by Pro at positions 60, 67, 74, and 81 within the leucine zipper-like
domain of wild-type Vpr and C81 revealed that the Ile/Leu residues at positions 60, 67, and 74 in the leucine zipper-like domain
were indispensable for induction of apoptosis induced by Vpr and by C81 and confirmed, in addition, that both processes
might be regulated by the same pathway. C81 appears to be a useful tool for elucidation of the mechanism of apoptosis
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INTRODUCTION
AIDS induced by human immunodeficiency virus type
1 (HIV-1) is characterized by the progressive depletion of
CD41 lymphocytes. Apoptosis is a major feature of the
pathogenesis of AIDS and is thought to play a role in the
progressive decrease in the number of CD41 lympho-
cytes in infected individuals (Estaquier et al., 1994; Finkel
and Banda, 1994; Gandhi et al., 1998; Meyaard et al.,
1992). The HIV-1 genome encodes not only structural and
replicative proteins (Gag, Pol, and Env) but also at least
six auxiliary proteins (Vif, Vpr, Tat, Rev, Vpu, and Nef) that
are capable of regulating viral replication and infectivity.
Mechanisms of induction of apoptosis that involve the
auxiliary genes of HIV-1 have been studied in detail
(Ayyavoo et al., 1997; Bartz and Emerman, 1999; Bodeus
et al., 1997; Casella et al., 1999; Conti et al., 1998; Fuku-
mori et al., 1998; Hanna et al., 1998; Lu et al., 1994;
Maldarelli et al., 1995; Stewart et al., 1997; Zauli et al.,
1999). We are interested in one of the accessory gene
products of HIV-1, Vpr, which is a 15-kDa nuclear protein
of 96 amino acids (Cohen et al., 1990). Vpr has many
biological functions, being involved in virion incorpora-
tion (Bachand et al., 1999; Kondo and Gottlinger, 1996;1 To whom correspondence and reprint requests should be ad-
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0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
16Kondo et al., 1995; Lavallee et al., 1994; Lu et al., 1995),
nuclear localization (Gallay et al., 1996; Heinzinger et al.,
1994; Jenkins et al., 1998; Lu et al., 1993; Popov et al.,
1998a,b; Vodicka et al., 1998), cell differentiation (Levy et
al., 1993), association with cellular factors (Agostini et al.,
1996; Bouhamdan et al., 1996; Mahalingam et al., 1998;
Refaeli et al., 1995; Sawaya et al., 1998; Wang et al., 1995;
ithers-Ward et al., 1997; Zhao et al., 1994), and cell cycle
rrest at the G2 phase. One of the important functions of
Vpr is to promote growth arrest at the G2/M phase of the
cell cycle by preventing the activation of the p34cdc2–
cyclin B complex by hyperphosphorylation of p34cdc2 at
pecific sites (Bartz et al., 1996; He et al., 1995; Jowett et
l., 1995; Re et al., 1995; Rogel et al., 1995). It remains to
e established whether Vpr-mediated G2 arrest plays a
ivotal role in viral replication in vivo. However, the ex-
ression of the viral genome is maximal during the G2
phase of the cell cycle and Vpr increases the production
of virus by delaying cells at that point in the cell cycle at
which the long terminal repeat (LTR) is most active (Fel-
zien et al., 1998; Goh et al., 1998). This observation
suggests that Vpr might play an important role in the life
cycle of HIV-1. Stewart et al. (Stewart et al., 1999) re-
ported that Vpr can interrupt the cell cycle at the G2/M
phase, with subsequent apoptosis. In particular, the in-
duction of G2 arrest, but not necessarily continued arrest
at G2, has been shown to be required for Vpr-induced
t
i
1
s
b
e
s
N
c
i
e
i
2
6
V
a
i
s
s
i
i
m
l
o
i
I
o
w
G
G
CED Bapoptosis. Other evidence also suggests that soluble Vpr
can regulate apoptosis both positively and negatively
(Ayyavoo et al., 1997). By contrast, there is also evidence
o suggest that Vpr might have an antiapoptotic function
n cells that stably express Vpr at a low level (Conti et al.,
998; Fukumori et al., 1998). Such studies suggest
trongly that Vpr is involved in the regulation of apoptosis
ut it remains unclear whether apoptosis is induced by
xpression of Vpr in cells.
In a previous study, we found that transient expres-
ion of Vpr interfered with the growth of mouse
IH3T3 fibroblastoid cells but failed to arrest these
ells at the G2 phase (Nishino et al., 1997). Our find-
ngs strongly suggest that Vpr might have another
ffect whereby it interferes with the growth of the cells
ndependently of G2 arrest. By analysis of the effect of
various expression vectors that encoded Vpr mole-
cules with deletions of specific putative domains, we
succeeded in identifying a carboxy-terminally trun-
cated form of Vpr, C81, that failed to induce G2 arrest,
but that retained the ability to prevent proliferation of
HeLa cells, in which the expression of Vpr can induce
G2 arrest (Nishizawa et al., 1999). More recent evi-
dence suggests that C81 can induce apoptosis
through G1 arrest of the cell cycle (Nishizawa et al.,
000). Replacement of Ile/Leu by Pro at positions 60,
7, 74, and 81 within the leucine zipper-like domain of
pr or of C81 revealed that Ile60, Leu67, and Ile74 play
n important role both in C81-induced G1 arrest and in
C81-induced apoptosis, while Ile74 and Ile81 appear to
be indispensable for Vpr-induced arrest at G2 (Nish-
zawa et al., 2000). Thus, the functional residues re-
quired for the induction of G2 arrest by Vpr and of
apoptosis by C81 appear to differ from one another.
Therefore, induction of G2 arrest and induction of ap-
optosis through G1 arrest are independent functions of
Vpr. These observations suggest that, as is the case
for C81, endogenous expression of Vpr might cause
apoptosis independently of the ability of Vpr to induce
G2 arrest of the cell cycle.
We demonstrate in the present report that the expres-
ion of Vpr at a high level induces apoptosis through the
ame pathway as the pathway that leads to apoptosis
nduced by C81 in HeLa cells. However, the activity of Vpr
s weaker than that of C81. Furthermore, by analysis of
utant forms of Vpr with the Ile/Leu residues in the
eucine zipper-like domain replaced by Ala or Pro, we
btained evidence that the Vpr protein causes apoptosis
n a manner that is independent of G2 arrest of the cell
cycle. In addition, our kinetic analysis of apoptosis and
G2 arrest suggested that apoptosis is initiated rapidly
before the induction of G2 arrest of the cell cycle. To the
best of our knowledge, this is the first report of a high-
APOPTOSIS INDUlevel expression of Vpr leading separately to apoptosis
and to G2 arrest.RESULTS
nduction of apoptosis upon transient expression
f Vpr
As described previously, C81, a truncated form of Vpr,
as able to induce apoptosis effectively without causing
2 arrest of the cell cycle (Nishizawa et al., 2000). By
contrast, it appeared that wild-type Vpr arrested cells at
the G2 phase with subsequent apoptosis (Stewart et al.,
1997) and it was unclear whether Vpr caused apoptosis
independently of its ability to induce G2 arrest. Therefore,
to examine the possible ability of Vpr protein to induce
apoptosis separately from G2 arrest in HeLa cells, we
choose the 24-h period after transfection as the time
period during which Vpr was expressed at detectable
levels but was minimally effective in inducing G2 arrest.
We transfected HeLa cells with pME18Neo that encoded
Flag-tagged wild-type Vpr or with control pME18Neo-
Flag, together with a small amount of the green fluores-
cent protein (GFP) expression vector pEGFP-N1, which a
served as a marker plasmid. The DNA content of GFP-
expressing cells was assessed by flow cytometry after
the cells were stained with propidium iodide (PI). As
indicated in Fig. 1Ab, no significant increase in cells of
G2 was observed 24 h after transfection with the wild-
type Vpr expression vector. Approximately 21.4% of cells
were in the G2 phase and the G2/M:G1 ratio was 0.35. In
Vpr-expressing cells, 72 h after transfection, approxi-
mately 60.1% of cells were in the G2 phase and the
2/M:G1 ratio was 5.30, as indicated in Fig. 1Ad. Twenty-
four hours after transfection, transfected HeLa cells were
harvested and lysed and the activity of caspase-3, a
signaling molecule in apoptotic pathways, was deter-
mined in the lysates. Vpr induced about 25.8% of the
activity observed after treatment of cells with actinomy-
cin D, a potent inducer of apoptosis (Fig. 1B). In addition,
the caspase-3 activity induced by wild-type Vpr was two-
to threefold lower than that induced by C81 (data not
shown). In order to analyze apoptosis in terms of the
binding of annexin V, which binds phosphatidylserine on
plasma membranes at an early stage of apoptosis, we
transfected HeLa cells with each expression vector to-
gether with a small amount of pEGFP-N1 and stained
cells with annexin V–biotin followed by streptavidin–PE
(Fig. 1C). When HeLa cells had been transiently cotrans-
fected with the wild-type Vpr expression vector, approx-
imately 23.9% of GFP-positive cells underwent apoptosis.
When cells had been transfected with the control expres-
sion vector, this value was approximately 6.3%. Similarly,
when HeLa cells had been transfected with the Vpr
expression vector together with pEGFP-N1, the presence
of apoptotic cells was apparent from the observation of
typical condensation, fragmentation, and clumping of
chromatin after staining with Hoechst 33258 (Fig. 1D).
17Y Vpr OF HIV-1HeLa cells transfected with the control vector did not
show any evidence of apoptosis. These results suggest
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when the induction of G2 arrest of the cell cycle was
inimal.
inetic analysis of apoptosis and G2 arrest induced
by Vpr
To determine the relationship between G2 arrest and
apoptosis, both of which could be induced by Vpr, we
analyzed the extent of apoptosis and G2 arrest at various
ime points after transfection with either pME18Neo that
ncoded Flag-tagged Vpr or control pME18Neo-Flag (Fig.
). G2 arrest occurred within 24 h and the G2/M:G1 ratio
egan to increase within 36 h when HeLa cells were
ransfected with the wild-type Vpr expression vector. The
atio continued to increase until 72 h after transfection.
y contrast, the activity of caspase-3 was highest 24 h
FIG. 1. Analysis of apoptosis in HeLa cells that expressed wild-type
control pME18Neo-Flag together with the GFP expression vector pEG
reporter molecule for discrimination between transfected and untransfe
cells were harvested for analysis of DNA content. They were stained w
described in the text. Arrows indicate peaks of cells at the G1 and G2/M
wenty-four hours after transfection, cells were harvested and lysed a
Act D), which is a potent inducer of apoptosis, was used as a positive c
–biotin followed by streptavidin–PE for identification of apoptotic cells
ours after transfection, cells were fixed and stained with Hoechst 33
dentified by microscopic analysis.
8 NISHIZfter transfection. It decreased rapidly within 36 h and
hen did not change significantly during the rest of thexperimental period. Thus, kinetic analysis suggested
hat the extent of apoptosis reached a maximum at 24 h
hen a few cells had been arrested at the G2 phase of
he cell cycle and then the extent decreased in inverse
roportion to the increase in the extent of induction of G2
arrest. The results suggest that the induction of G2 arrest
by Vpr was not correlated with the extent of the induction
of apoptosis.
Effects of substitution of Ile/Leu residues by Ala or
Pro in the leucine zipper-like domain of wild-type Vpr
To determine whether Vpr can induce apoptosis via a
mechanism different from that by which it arrests cells at
the G2 phase of the cell cycle, we focused on the leucine
zipper-like domain, from amino acids 60 to 81, of Vpr.
Such domains have been found in a variety of transcrip-
La cells transfected with pME18Neo that encoded Flag-tagged Vpr or
(A, C, and D) or the b-galactosidase plasmid (B). GFP was used as a
lls. (A) Twenty-four hours (a and b) or 72 h (c and d) after transfection,
and cells that were GFP-positive were analyzed by flow cytometry as
es. The G2/M:G1 ratio is indicated in the upper right of each graph. (B)
ase-3 activity was measured as described in the text. Actinomycin D
C) Twenty-four hours after transfection, cells were stained with annexin
that were GFP-positive were identified for comparison. (D) Twenty-four
visualization of apoptotic morphology. Apoptosis cells (arrows) were
T AL.Vpr. He
FP-N1
cted ce
ith PI
phas
nd casp
ontrol. (
. Cells
AWA Etional factors and can provide sites for direct contacts
with other protein.
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CED BWe prepared expression vectors in which Leu67 and
Ile74 of Vpr were replaced by Ala to introduce changes in
its leucine zipper-like domain. The mutant proteins were
designated L67A, I74A, and L67/I74A (Fig. 3A) and the
corresponding expression vector, and the wild type, were
used to transfect HeLa cells. Western blotting with mono-
clonal antibody (MAb) M2 revealed that each Vpr protein
with a site-specific mutation was expressed at detect-
able levels in the corresponding transfected cells 24 h
after transfection (Fig. 3B). We examined the extent of
apoptosis by measuring caspase-3 activity, annexin V
binding, and Hoechst 33258 staining, and we monitored
G2 arrest by flow cytometry (Fig. 4 and Table 1). All three
utant proteins retained the ability to induce G2 arrest,
albeit to a greater extent than wild-type Vpr (L67A, I74A,
and L67/I74A: approximately 2.5-fold, 17.5-fold, and 3.7-
fold), as compared to wild-type Vpr, respectively (Fig. 4A).
G2 arrest was even more prominent 36 h after transfec-
ion and continued until 72 h after transfection (Table 1).
n the other hand, only two mutant proteins, namely I74A
nd L67/I74A, completely lost the ability to induce apo-
tosis as shown by a lack of caspase-3 activity 24 h after
ransfection (Fig. 4B) and exhibited very weak caspase-3
ctivity at 72 h (Table 1). By contrast, the caspase-3
FIG. 2. Kinetics of changes in the G2/M:G1 ratio and on caspase-3
activity in HeLa cells that expressed the Vpr protein. HeLa cells were
transfected with pME18Neo that encoded Flag-tagged wild-type Vpr (F)
or the control plasmid pME18Neo-Flag () together with the GFP
expression vector pEGFP-N1 (A) or the b-galactosidase plasmid (B).
The G2/M: G1 ratio (A) and caspase-3 activity (B) of HeLa cells were
etermined 12, 24, 36, 48, 60, and 72 h after transfection.
APOPTOSIS INDUctivity induced by L67A mutant protein retained a low
evel until 72 h after transfection. When HeLa cells thatad been transiently transfection with I74A and L67/I74A
xpression vectors were examined by annexin V binding
nd Hoechst 33258 staining, only a small population of
ells in which GFP emitted green fluorescence under-
ent apoptosis, although these values were close to that
n the case of HeLa cells transfected with the control
xpression vector (Fig. 4C).
Next, we transiently transfected HeLa cells with ex-
ression vectors that encoded Vpr in which Ile/Leu res-
dues at positions 60, 67, 74, and 81 in the leucine zipper-
ike domain were replaced by Pro residue(s) as de-
cribed in Fig. 3A. Within 24 h after transfection, each
utant protein was expressed at detectable levels in the
orresponding transfected cells by Western blotting (Fig.
B). In our previous paper (Nishizawa et al., 1999), we
showed that 36 h after transfection a small percentage of
cells transfected with I60P and L67P expression vectors
were arrested in the G2 phase (Table 1). However, in this
report we show that 24 h after transfection the cells did
not yet show G2 arrest (Fig. 4A). By contrast, the activity
of caspase-3 indicated that, after transfection of HeLa
cells with I60P, L67P, and I74P expression vectors, there
was a marked decrease in the induction of caspase-3.
Only the I81P mutant protein retained almost the
caspase-3-induction activity (approximately 86.3%) of
FIG. 3. Construction and expression of the substitution mutant Vpr
proteins. (A) Ile/Leu residues at positions 60, 67, 74, and 81 in the
leucine-zipper like domain (represented by dark shading) were re-
placed by Ala or Pro; gray shading represents the Flag tag. (B) Western
blotting of mutant Vpr protein. HeLa cells were cotransfected with
pME18Neo that encoded Flag-tagged Vpr or mutant Vpr or control
pME18Neo-Flag together with the b-galactosidase plasmid. Twenty-
our hours after transfection, cells were harvested and some cells were
ubjected to an assay for b-galactosidase activity and the rest were
lysed. Lysates with equal b-galactosidase activity were subjected to
19Y Vpr OF HIV-1Western blotting analysis with the Flag-specific MAb M2. Positions of
the molecular mass markers (kDa) are indicated.
cp
e
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i
r staininwild-type Vpr (Fig. 4B). These data showed a similar
disposition to results as assessed by other methods
such as annexin V binding and Hoechst 33258 staining
(Fig. 4C), although the inductions of apoptosis by the
FIG. 4. Analysis of the cell cycle and apoptosis of HeLa cells that ex
ME18Neo that encoded Flag-tagged Vpr or mutant Vpr or control
xpression vector pEGFP-N1 (A and C). (A) The DNA content of cells w
ndicated in the upper right of each histogram. (B) Cells were harves
b-galactosidase activity and the rest were lysed. Lysates with equal b-
n the text. Each column and error bar represent the means 6 SD of resu
after transfection, cells were stained with annexin V–biotin followed by
in 1% of formaldehyde and then in 70% ethanol and stained with Hoechs
or apoptotic cells with the condensation and clumping of chromatin afte
of each panel. Apoptotic cells (arrowheads) are indicated.
20 NISHIZI81P mutant protein are approximately 45.0 and 43.7% of
that of wild-type Vpr. Thus, while Vpr-induced apoptosis
s
twas almost eliminated by replacement of Ile/Leu resi-
dues at positions 60 and 67 by Pro, the ability to induce
G2 arrest was still apparent, albeit at a later time point. By
ontrast, apoptosis-inducing activity was retained after
d the substitution mutants of Vpr. HeLa cells were cotransfected with
eo-Flag together with the b-galactosidase plasmid (B) or the GFP
rmined by flow cytometry 24 h after transfection. The G2/M:G1 ratio is
h after transfection and some cells were subjected to an assay for
sidase activity were subjected to an assay of caspase-3, as described
three samples in two independent experiments. (C) Twenty-four hours
vidin–PE for identification of apoptotic cells. Moreover, cells were fixed
to monitor the morphology. The percentage of annexin V-positive cells
g with Hoechst 33258/GFP-positive cells is indicated in the upper right
T AL.presse
pME18N
as dete
ted 24
galacto
lts from
strepta
t 33258
AWA Eubstitution of the Ile residue at position 81 by Pro, but
he ability to induce G2 arrest was completely lost.
21APOPTOSIS INDUCED BY Vpr OF HIV-1FIG. 4—Continued
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the ability to induce G2 arrest of the cell cycle was not
orrelated with the ability to induce apoptosis, these two
unctions of Vpr must involve different pathways.
omparison of the effects of substitution of Ile/Leu
esidues in the leucine zipper-like domain of wild-type
pr and C81
As described above, it appeared that Vpr could induce
poptosis independently of G2 arrest, as was also the
case for the C81 mutant (Nishizawa et al., 2000). There-
fore, to determine whether apoptosis in each case was
regulated by an independent pathway or by the same
pathway, we compared the effects of substitutions within
the leucine zipper-like domain on the extent of apoptosis
induced by Vpr and by C81 (Table 2). Results for cells
transfected with derivatives of pME18Neo that encoded
mutant forms of Vpr, such as I60P, L67P, I74P, and I81P,
T
Effects on Apoptosis and G2 Arrest of the Substitution of Ile/L
Expressed protein
Apoptosis
After 24 h After 72 h
Vpr 111 6
I60P 6 NDb
L67P 6 ND
I74P 2 ND
I81P 11 2
L67A 1 6
I74A 2 6
L67/I74A 2 6
a Activities are summarized as follows, with wild-type activity determ
50%; 1, 49 to 10%; 6, 9 to 1%; 2, ,1%.
b ND, not determined.
TABLE 2
Summary of the Effects on Apoptosis of the Substitution of Ile/Leu
Residues by Pro within the Leucine Zipper-like Domain of Wild-Type
Vpr and C81a
Position of substitution Vpr C81
None 111b 11111
60 6 2
67 6 2
74 2 6
81 11 11
a Twenty-four hours for wild-type Vpr and 36 h for C81 after transfec-
tion, HeLa cells were harvested for caspase-3 assay.
b Effect on activity, compared to that of wild-type Vpr, which was
22 NISHIZt
e
taken as 100%: 11111, .300%; 111, 100 to 80%; 11, 79 to 50%; 1,
49 to 10%; 6, 9 to 1%; 2, ,1%.and mutant forms of C81, such as C81/I60P, C81/L67P,
C81/I74P, and C81/I81P, are summarized in Table 2. Vpr
mutant proteins such as I60P, L67P, and I74P had almost
no ability to induce apoptosis, while I81P retained some
ability to induce apoptosis (Fig. 4 and Table 2). Similarly,
among the four substitution mutants of C81, only C81/
I81P partially retained the ability to induce apoptosis, as
reported previously (Nishizawa et al., 2000) (Table 2).
These results indicate that the Ile/Leu residues at posi-
tions 60, 67, and 74 in the leucine zipper-like domain are
indispensable for induction of apoptosis by Vpr and by
C81 and, moreover, they confirm that, in both cases,
apoptosis might be induced through the same pathway.
DISCUSSION
After the arrest of cells at the G2 phase, Vpr induces
poptosis in human fibroblasts, T cells, and primary
eripheral blood lymphocytes (Stewart et al., 1997). Vi-
ion-associated Vpr efficiently induces cell cycle arrest
nd apoptosis (Stewart et al., 1999) in cell lines derived
rom various tumors. In addition, soluble Vpr has been
hown to modulate T-cell-receptor-triggered apoptosis
imilarly to glucocorticoids (Ayyavoo et al., 1997). A car-
oxy-terminally truncated form of Vpr, designated C81,
oes not induce G2 arrest but induces apoptosis through
1 arrest (Nishizawa et al., 2000). This observation sug-
gests that the expression of wild-type Vpr in cells might
induce apoptosis independently of G2 arrest of cell cycle.
In the present study we demonstrated that Vpr, ex-
pressed transiently in cells, can induce apoptosis inde-
pendently of G2 arrest, resembling C81 in this regard.
The extent of Vpr-induced G2 arrest was not correlated
ith the extent of induction of apoptosis, as indicated by
idues within the Leucine Zipper-like Domain of Wild-Type Vpr
Activitya
G2 arrest
After 24 h After 36 h After 72 h
1 111 111
2 1 ND
2 1 ND
2 2 ND
2 2 2
11 111 11
111 111 11
11 111 11
caspase-3 assay being taken as 100%: 111, 100 to 80%; 11, 79 to
T AL.ABLE 1
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AWA Ehe following results. Kinetic analysis revealed that the
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CED Bfection, when few cells were arrested at the G2 phase of
the cell cycle. Moreover, the extent of apoptosis de-
creased at the same time as the induction of G2 arrest
ecame more prominent. Measurements of caspase-3
ctivity and studies of annexin V binding and Hoechst
3258 staining revealed apoptosis in Vpr-expressing
eLa cells 24 h after transfection, at a time when no
ignificant induction of G2 arrest was observed. Analysis
f the effects of mutant Vpr proteins also indicated that
he two functions of Vpr involve different regions of the
rotein. Vpr-induced apoptosis did not occur when the Ile
esidue at position 74 was changed to Ala but the ability
o induce G2 arrest was retained. Conversely, apoptotic
activity was retained after substitution of the Ile residue
at position 81 by Pro but the ability to induce G2 arrest
was lost. In addition, it appeared that the Ile/Leu resi-
dues at positions 60 and 67 were necessary for nuclear
localization of Vpr (Kamata and Aida, 2000), indicating
that inductions of apoptosis and G2 arrest by Vpr are not
elated to the distribution of Vpr protein. Thus, our
resent findings indicated that apoptosis and G2 arrest
might be induced through different pathways. This hy-
pothesis is supported by our earlier observations that
transient expression of Vpr interfered with the growth of
mouse NIH3T3 fibroblastoid cells but failed to arrest
these cells at the G2 phase (Nishino et al., 1997).
Vpr protein can be divided into four putative domains
on the basis of its amino acid sequence: the first a-he-
lical domain; the second a-helical domain; the leucine
ipper-like domain; and the arginine-rich carboxy-termi-
al domain (Lu et al., 1993; Yao et al., 1995; Zhou et al.,
998). In the present study, we focused on amino acids
0 to 81 in the leucine zipper-like domain as an important
unctional determinant of Vpr protein, such as nuclear
ocalization of Vpr protein, induction of G2 arrest of cell
cycle, and the specific interaction with host cellular pro-
tein (Nishizawa et al., 1999, 2000). Results obtained by
substitution of Ile/Leu by Pro at positions 60, 67, 74, and
81 within the leucine zipper-like domain of Vpr clearly
indicated that the residues critical for induction of apo-
ptosis are the Ile/Leu residues at positions 60, 67, and 74.
In our previous study we found that the same residues
are required for induction of apoptosis by C81. These
findings strongly suggest that induction of apoptosis by
Vpr without G2 arrest might involve the same pathway as
hat of induction of apoptosis by C81. However, our data
Fig. 2) suggest that the strong induction of G2 arrest
ight inhibit the function of apoptosis, namely when the
xpression of Vpr at high levels induces extensive G2
arrest. The level of caspase-3 activity induced by C81,
which was unable to induce G2 arrest, was two- to
threefold higher than that induced by wild-type Vpr in
HeLa cells and was as high as the activity induced by
actinomycin D, which is an inducer of apoptosis (Nish-
APOPTOSIS INDUizawa et al., 2000). Thus, C81 appeared to be a useful
tool for elucidation of the mechanism of induction of
o
sapoptosis by Vpr in the absence of the induction of G2
arrest. It is likely, in fact, that C81 induces apoptosis
through G1 arrest of the cell cycle. Further studies are
required to determine whether Vpr might also be able to
induce apoptosis that is related to G1 arrest.
We provide here the first evidence that Vpr can induce
poptosis independently of its ability to induce G2 arrest.
owever, our results differ from those reported by Stew-
rt et al. (Stewart et al., 1997), who indicated that Vpr
induces apoptosis after G2 arrest. They proposed that
induction of G2 arrest was necessary to trigger apopto-
sis. They found that, upon expression of Vpr, either alone
as a result of transfection or in the context of viral
infection, G2 arrest was followed by increased cell death
that is detectable at 30 h and then peaks 60 to 90 h after
infection or transfection. Their analysis of the effects of
various mutations in the vpr gene indicated that the
extent of Vpr-induced G2 arrest was closely correlated
with the extent of apoptosis. The discrepancy between
our data and those of Stewart et al. might be related to
the times at which cells were examined as well as the
cell lines used in the analysis. Specifically, Stewart et al.
monitored infected or transfected cells at 21, 45, 69, 91,
and 123 h, whereas we observed that the extent of
apoptosis was maximal at 24 h and decreased 36 h after
transfection. Such effects might have been missed Stew-
art et al. Moreover, Stewart et al. used synchronized
HeLa cells, the human T-cell line SupT1, and stimulated
peripheral blood lymphocytes, while we used nonsyn-
chronized HeLa cells. In addition, the difference may lie
in the transfection methods. It is also likely that the
discrepancies are due to the differences in point muta-
tions in Vpr. Mutations of Arg 80 to Ala and Ala 30 to Pro
by Stewart et al. resulted in a severe reduction of the
xtent of both G2 arrest and apoptosis, while the substi-
tution by our group of Ile/Leu residues at positions 60, 67,
and 81 in the leucine zipper-like domain of Vpr revealed
the absence of any correlation between the extent of cell
cycle arrest and the extent of apoptosis.
Our data suggest that Vpr-induced apoptosis might
play a role in the death of infected T cells in cases of
infection by HIV-1. However, stable expression of Vpr at a
low level has been reported to have a strong antiapop-
totic effect (Conti et al., 1998; Fukumori et al., 1998). It
ppears that low levels of expression of Vpr protect cells
rom apoptosis induced by different stimuli and can in-
erfere with the physiological turnover of T lymphocytes
t the early stages of viral infection, thereby facilitating
he persistence of HIV and, subsequently, the spread of
he virus (Conti et al., 1998). Ayyavoo et al. (Ayyavoo et al.,
997) suggested that soluble Vpr might be able to regu-
ate apoptosis both positively and negatively, with T-cell-
eceptor-triggered apoptosis depending on the state of
mmune activation. Most viruses have evolved a number
23Y Vpr OF HIV-1f strategies for both inhibition and activation of apopto-
is at various stages of the apoptotic pathway (Theodore
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AWA Eet al., 1996). Therefore, expression of Vpr might prevent
or delay early apoptosis, allowing the production of prog-
eny virus at high yield. Vpr has been shown to increase
the production of virus by delaying cells at that point in
the cell cycle at which the LTR is most active (Felzien et
al., 1998; Goh et al., 1998). However, additional studies
are needed to determine exactly how inhibition of cellu-
lar proliferation, delays in the cell cycle, and apoptosis
might influence viral replication soon after the infection
of cells, to aid in the establishment of the virus, and at
later times. Similarly, how the balance between the Vpr-
induced delay in apoptosis and G2 arrest is regulated
during the life cycle of HIV and during the progression of
AIDS pathogenesis remains to be determined.
MATERIALS AND METHODS
Construction of plasmids
Generation of the expression vector pME18Neo that
encoded Flag-tagged wild-type Vpr; substitution mutants
of Vpr designated I60P, L67P, I74P, and I81P; C81; substi-
tution mutants of C81 designated C81/I60P, C81/L67P,
C81/I74P, and C81/I81P, and generation of the control
plasmid pME18Neo-Flag have been described previ-
ously (Nishino et al., 1997; Nishizawa et al., 1999). To
generate the substitution mutants designated, L67A,
I74A, and L67/I74A, we introduced site-specific mutations
into pSK-Fvpr (Nishizawa et al., 1999) by ExSite PCR-
based site-directed mutagenesis using a kit from Strat-
agene (La Jolla, CA). Leu or Ile codons of the leucine-
zipper like domain were changed to Ala codons by long
and accurate PCR with pSK-Fvpr as the template and the
following primers: 59-GA ATT CTG CAA CAG GCC TTA
TTT ATC CAT TTC-39 and 59-TTA TTA TGG CTT CCA CTC
CTG CCC AAG TAT CCC CGT AAG-39 for L67A; 59-GGC
TGT CGA CAT AGC AGA ATA G-39 and 59-GGC TCT GAA
ATG GAT AAA CAG C-39 for I74A; and 59-AAT TCT GCA
ACA AGC CCT GTT TAT CCA TTT CAG AGC CGG CTG-39
and 59-T CGA CAG CCG GCT CTG AAA TGG ATA AAC
AGG GCT TGT TGC AG-39 for L67/I74A. Each XhoI–NotI
fragment, including the site-mutated vpr gene and Flag
sequences, in pSK-Fvpr was excised and subcloned into
pME18Neo. All constructs described above were verified
by nucleotide sequencing by the dideoxy chain-termina-
tion method with a BcaBEST dideoxy sequencing kit
(Takara, Otsu, Japan). pEGFP-N1 encoded a “red-shifted”
variant of wild-type GFP that had been modified for
brighter fluorescence and has been used for flow cyto-
metric analysis (Cormack et al., 1996). pSV-b-Galactosi-
dase encoded a bacterial b-galactosidase and was in-
luded for normalization of efficiencies of transfection.
ell culture and transfections
24 NISHIZHuman cervical HeLa cells were maintained in RPMI
640 medium supplemented with 10% heat-inactivatedetal calf serum (FCS), penicillin (100 U/ml), and strepto-
ycin (100 mg/ml). Cells (1 3 107) were transfected with
7.5 mg of a Vpr expression plasmid together with or
ithout 2.5 mg of pSV-b-galactosidase or 2.5 mg of
pEGFP-N1 by electroporation in a 0.4-cm-diameter cu-
vette using a Bio-Rad gene pulsar (Richmond, CA) at 300
V and 975 mF.
nalysis of the cell cycle
DNA content was analyzed with PI as described pre-
iously (Nishizawa et al., 1999). HeLa cells were cotrans-
ected with 47.5 mg of a Vpr expression plasmid and 2.5
mg of pEGFP-N1. They were harvested at various times,
fixed in 1% formaldehyde and 70% ethanol, and then
incubated in phosphate-buffered saline (PBS) that con-
tained PI (50 mg/ml), RNase A (50 mg/ml), and FCS (2%,
v/v) for 60 min at room temperature. The fluorescence of
10,000 cells was analyzed on a FACScan system (Bec-
ton–Dickinson, Mountain View, CA) with Lysis II software
(Becton–Dickinson). Data presented are after gating to
eliminate cells in which GFP did not emit strong fluores-
cence. Ratios of numbers of cells in the G2/M phase and
G1 (G2/M:G1 ratios) were calculated with ModFit LT soft-
are (Verity Software House, Topsham, ME).
poptosis analysis
The extent of apoptosis was monitored by three differ-
nt methods, as described previously (Nishizawa et al.,
000).
After transfection with 47.5 mg of a Vpr expression
plasmid and 2.5 mg of pEGFP-N1, HeLa cells growing on
coverslips were stained with incubation buffer (10 mM
HEPES/NaOH, pH 7.4, 140 mM NaCl, and 5 mM CaCl2)
hat contained annexin V–biotin (Boehringer Mannheim,
annheim, Germany) for 15 min. They were then washed
ith incubation buffer and stained by treatment with
ncubation buffer containing streptavidin–PE (Becton–
ickinson). Stained cells were washed several times
ith incubation buffer, fixed in incubation buffer that
ontained 0.25% glutaraldehyde and 3.7% formaldehyde,
nd mounted on glass slides in PBS that contained 50%
lycerol, 0.1% p-phenylene diamine, and 0.02% sodium
zide. Cells were examined under a confocal laser scan-
ing microscope (LSM10; Carl Zeiss, Jena, Germany).
Hoechst 33258, which stains chromatin, was used to
isualize the condensation and clumping of chromatin,
s described elsewhere (Nicoletti et al., 1991). After
ransfection with 47.5 mg of a Vpr expression plasmid
and 2.5 mg of pEGFP-N1, HeLa cells growing on cover-
slips were fixed with 1% formaldehyde and then with 70%
ethanol, and fixed cells were stained with Hoechst 33258
(Sigma St. Louis, MO). Apoptotic bodies were character-
ized by microscopy.
T AL.The activity of caspase-3 was determined with a
CPP32/Caspase-3 colorimetric protease assay kit (MBL,
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CED BNagoya, Japan) according to the instructions from the
manufacturer. After transfection with 47.5 mg of a Vpr
xpression plasmid and 2.5 mg of pSV-b-galactosidase,
HeLa cells were harvested at various times. At each time
point, some cells were subjected to an assay of b-Gal
ctivity (b-Gal reporter gene assay kit, Boehringer Mann-
eim), and the rest were lysed in lysis buffer. The cell
ysate (200 mg/50 ml protein) was incubated with DEVD–
pNA substrate for 1 h at 37°C, and the amount of p-
nitroanilide forms was quantitated spectrophotometri-
cally at 405 nm. As a positive control, actinomycin D (1
mg/ml) was added to HeLa cells and the cells were lysed
at 6 h after treatment and subjected to an assay of
caspase-3 activity.
Western blotting
Twenty-four hours after transfection, cells were har-
vested and divided into two portions. Some cells were
subjected to an assay of b-Gal activity, and the rest were
ysed with a 1% solution of sodium dodecyl sulfate (SDS)
hat contained 1 mM phenylmethylsulfonyl fluoride. The
ixture was then immediately boiled for 5 min. The
aterial in the cell lysate was solubilized in Laemmli’s
uffer (Laemmli, 1970) and subjected to SDS–PAGE on a
5% polyacrylamide gel. Then proteins were transferred
lectrophoretically to a polyvinylidene difluoride mem-
rane filter (Immobilon; Millipore, Bedford, MA). The
embrane was incubated in buffer that contained either
nti-Flag-specific MAb M2 (Eastman Kodak, Rochester,
Y) or normal mouse serum and then it was incubated
ith horseradish-peroxidase-conjugated sheep antibod-
es against mouse Ig (Amersham Pharmacia Biotech,
ppsala, Sweden). Signals were visualized after treat-
ent of the filter with enhanced chemiluminescence
etection reagents (NEN, Boston, MA).
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